tirzepatide for kidney disease 𧬠New data from the SUMMIT trial reveals that long-term (Zepbound) may significantly improve function in patients with obesity, chronic kidney (CKD), and heart failure with preserved ejection fraction ( Weight Loss - Rejuvenescence Med
Description
Table 1 summarizes these findings
When to Expect Results If youre switching because of a Wegovy plateau, dont expect immediate breakthroughs
in Physician Assistant Studies, Stony Brook University B.S in Biology, Molloy College NCCPA Certification AASM Member Learn More Awards & Recognitions
As the HR was derived from an intention-to-treat analysis, it reflected real-world patterns of adherence and discontinuation observed in the trial
The results reveal meaningful evidencepractice gaps in primary care settings
